[go: up one dir, main page]

CH415631A - Process for the preparation of α- (3-indolyl) -lower aliphatic-acids - Google Patents

Process for the preparation of α- (3-indolyl) -lower aliphatic-acids

Info

Publication number
CH415631A
CH415631A CH983860A CH983860A CH415631A CH 415631 A CH415631 A CH 415631A CH 983860 A CH983860 A CH 983860A CH 983860 A CH983860 A CH 983860A CH 415631 A CH415631 A CH 415631A
Authority
CH
Switzerland
Prior art keywords
indolyl
acids
preparation
lower aliphatic
aliphatic
Prior art date
Application number
CH983860A
Other languages
German (de)
Inventor
Shen Tsung-Ying
Hastings Sarett Lewis
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH415631A publication Critical patent/CH415631A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH983860A 1959-09-03 1960-08-31 Process for the preparation of α- (3-indolyl) -lower aliphatic-acids CH415631A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83777459A 1959-09-03 1959-09-03

Publications (1)

Publication Number Publication Date
CH415631A true CH415631A (en) 1966-06-30

Family

ID=25275378

Family Applications (1)

Application Number Title Priority Date Filing Date
CH983860A CH415631A (en) 1959-09-03 1960-08-31 Process for the preparation of α- (3-indolyl) -lower aliphatic-acids

Country Status (5)

Country Link
BE (1) BE594596A (en)
CH (1) CH415631A (en)
ES (1) ES260797A1 (en)
GB (1) GB948460A (en)
NO (1) NO116545B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB957990A (en) * 1961-03-14 1964-05-13 Merck & Co Inc Salts of substituted indoles
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs

Also Published As

Publication number Publication date
ES260797A1 (en) 1961-04-01
BE594596A (en) 1961-02-28
NO116545B (en) 1969-04-14
GB948460A (en) 1964-02-05

Similar Documents

Publication Publication Date Title
CH370197A (en) Process for the preparation of actinospectacin
CH387047A (en) Process for the preparation of ketosidopurines
CH400144A (en) Process for the preparation of 16-methylene-17a-hydroxy-progesterone-17-acylates
CH419127A (en) Process for the preparation of substituted 3-pyrrolidinols
CH426822A (en) Process for the preparation of α- (3-indolyl) -lower aliphatic-acids
CH404962A (en) Process for the preparation of eupolyoxymethylenes
CH396026A (en) Process for the preparation of haloalkylamines
CH415631A (en) Process for the preparation of α- (3-indolyl) -lower aliphatic-acids
CH399742A (en) Process for the preparation of eupolyoxymethylenes
CH387606A (en) Process for the preparation of tetrahydroxydiboron
CH387029A (en) Process for the preparation of 9a-fluoro-11B-oxy-16a-methylprogesterone
CH408916A (en) Process for the preparation of α- (1-benzyl-3-indolyl) -lower aliphatic acids
CH538458A (en) Process for the preparation of α-dithiosemicarbazones
CH372297A (en) Process for the preparation of 4-2-tert-aminomethyl-3-keto-steroids
CH380730A (en) Process for the preparation of 4-methoxy-2-methyl-6-sulfanilamidopyrimidine
CH417595A (en) Process for the preparation of alkyl-5-alkylisoxazole-3-carboxylates
CH395992A (en) Process for the preparation of 1- (o-tolyloxyethyl) -4-phenyl-piperidine
CH400110A (en) Process for the preparation of 2-trifluoromethylbenzhydrol
CH378344A (en) Process for the preparation of 2-amino-anthraquinones
CH395968A (en) Process for the preparation of cyclopropane derivatives
AT221092B (en) Process for the preparation of substituted 2-oxo-benzoquinolizines
CH385849A (en) Process for the preparation of substituted 2-oxobenzoquinolizines
AT221494B (en) Process for the preparation of α-amino-ω-lactams
AT221096B (en) Process for the preparation of 2-hydrazino-3-mercapto-quinoxaline
AT221103B (en) Process for the preparation of monoalkylphosphines